Jong Joseph Kim - Chief Executive Officer, Director at INOVIO PHARMACEUTICALS, INC.

Issuer-level insider activity

Role
Chief Executive Officer, Director
Issuer ticker
INO on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Jong Joseph Kim since 10 Aug 2025

Reported holdings for Jong Joseph Kim in INOVIO PHARMACEUTICALS, INC.

Form 4 holding Chief Executive Officer, Director

INOVIO PHARMACEUTICALS, INC.

Security class
Restricted Stock Unit
Shares / value
139,386
Estimated value
$1,137,390
Report date
11 Mar 2022
Price
$8.16
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

INOVIO PHARMACEUTICALS, INC.

Security class
Common Stock
Shares / value
1,422,627
Estimated value
$796,671
Report date
11 Mar 2022
Price
$0.5600
Ownership
Direct
Form 4 holding Chief Executive Officer, Director

INOVIO PHARMACEUTICALS, INC.

Security class
Common Stock
Shares / value
816,527
Estimated value
$457,255
Report date
11 Mar 2022
Price
$0.5600
Ownership
By Family Limited Partnership
Form 4 holding Chief Executive Officer, Director

INOVIO PHARMACEUTICALS, INC.

Security class
Common Stock
Shares / value
33,775
Estimated value
$18,914
Report date
11 Mar 2022
Price
$0.5600
Ownership
By Son: JK1
Form 4 holding Chief Executive Officer, Director

INOVIO PHARMACEUTICALS, INC.

Security class
Common Stock
Shares / value
33,563
Estimated value
$18,795
Report date
11 Mar 2022
Price
$0.5600
Ownership
By Daughter: EK
Form 4 holding Chief Executive Officer, Director

INOVIO PHARMACEUTICALS, INC.

Security class
Common Stock
Shares / value
33,533
Estimated value
$18,778
Report date
11 Mar 2022
Price
$0.5600
Ownership
By Son: JK2
Form 4 holding Chief Executive Officer, Director

INOVIO PHARMACEUTICALS, INC.

Security class
Common Stock
Shares / value
5,975
Estimated value
$3,346
Report date
11 Mar 2022
Price
$0.5600
Ownership
By Spouse
Form 4 holding Chief Executive Officer, Director

INOVIO PHARMACEUTICALS, INC.

Security class
Common Stock Option
Shares / value
627,700
Estimated value
Report date
26 Feb 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Jong Joseph Kim in INOVIO PHARMACEUTICALS, INC.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .